Harmony Biosciences Stock Options
| HRMY Stock | USD 29.23 0.38 1.32% |
Harmony Biosciences' option chain provides insight into all available option contracts written on Harmony Biosciences' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Harmony Biosciences' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Harmony option contract.
In The Money vs. Out of Money Option Contracts on Harmony Biosciences
Analyzing Harmony Biosciences' in-the-money options over time can help investors to take a profitable long position in Harmony Biosciences regardless of its overall volatility. This is especially true when Harmony Biosciences' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Harmony Biosciences' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Harmony Biosciences' stock while costing only a fraction of its price.
Harmony Biosciences' latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 78.04 with a put-to-call open interest ratio of 0.33 over 20 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 3, with calls trading at the volume of 20. This yields a 0.15 put-to-call volume ratio. The Harmony Biosciences option chain provides detailed quote and price information for the current Harmony Biosciences Holdings option contracts. It shows all of Harmony Biosciences' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-17 Option Contracts
Harmony Biosciences option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Harmony Biosciences' lending market. For example, when Harmony Biosciences' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Harmony Biosciences, he or she must hedge the risk by shorting Harmony Biosciences stock over its option's life.
2024-05-17
The chart above shows Harmony Biosciences' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Harmony Biosciences' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Harmony Biosciences' option, there is no secondary market available for investors to trade.
Harmony Biosciences Maximum Pain Price across 2024-05-17 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Harmony Biosciences close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Harmony Biosciences' stock options are financial instruments that give investors the right to buy or sell shares of Harmony Biosciences common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Harmony stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Harmony Biosciences' stock price goes up or down, the stock options follow.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harmony Biosciences Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. Please note that buying 'in-the-money' options on Harmony Biosciences lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Harmony Biosciences' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Harmony Biosciences contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Harmony Stock moves the wrong way.
At this time, Harmony Biosciences' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 64.3 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 466 M in 2024. Harmony Biosciences In The Money Call Balance
When Harmony Biosciences' strike price is surpassing the current stock price, the option contract against Harmony Biosciences Holdings stock is said to be in the money. When it comes to buying Harmony Biosciences' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Harmony Biosciences Holdings are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Harmony Current Options Market Mood
Harmony Biosciences' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Harmony Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Harmony Biosciences' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Harmony Biosciences' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Harmony Biosciences' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Harmony contract
Base on the Rule 16, the options market is currently suggesting that Harmony Biosciences Holdings will have an average daily up or down price movement of about 4.88% per day over the life of the 2024-05-17 option contract. With Harmony Biosciences trading at USD 29.23, that is roughly USD 1.43. If you think that the market is fully incorporating Harmony Biosciences' daily price movement you should consider buying Harmony Biosciences Holdings options at the current volatility level of 78.04%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Harmony |
Purchasing Harmony Biosciences options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Harmony calls. Remember, the seller must deliver Harmony Biosciences Holdings stock to the call owner when a call is exercised.
Harmony Biosciences Option Chain
When Harmony Biosciences' strike price is surpassing the current stock price, the option contract against Harmony Biosciences Holdings stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Harmony Biosciences' option chain is a display of a range of information that helps investors for ways to trade options on Harmony. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Harmony. It also shows strike prices and maturity days for a Harmony Biosciences against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-17 CALL at $15.0 | 0.9254 | 0.0086 | 0 | 2024-05-17 | 13.0 - 16.2 | 0.0 | In |
Call | 2024-05-17 CALL at $17.5 | 0.9151 | 0.0124 | 0 | 2024-05-17 | 10.5 - 13.5 | 0.0 | In |
Call | 2024-05-17 CALL at $20.0 | 0.8944 | 0.0185 | 0 | 2024-05-17 | 7.8 - 11.2 | 0.0 | In |
Call | 2024-05-17 CALL at $22.5 | 0.8369 | 0.0281 | 0 | 2024-05-17 | 5.8 - 8.8 | 0.0 | In |
Call | 2024-05-17 CALL at $25.0 | 0.7929 | 0.0482 | 10 | 2024-05-17 | 3.7 - 5.7 | 4.85 | In |
Call | 2024-05-17 CALL at $30.0 | 0.463 | 0.0724 | 45 | 2024-05-17 | 0.85 - 2.35 | 1.74 | Out |
Call | 2024-05-17 CALL at $35.0 | 0.1222 | 0.0459 | 92 | 2024-05-17 | 0.2 - 0.6 | 0.25 | Out |
Put | 2024-05-17 PUT at $22.5 | -0.1288 | 0.0292 | 0 | 2024-05-17 | 0.1 - 1.2 | 0.52 | Out |
Put | 2024-05-17 PUT at $25.0 | -0.2319 | 0.0444 | 2 | 2024-05-17 | 0.25 - 1.95 | 1.05 | Out |
Put | 2024-05-17 PUT at $30.0 | -0.5391 | 0.0727 | 62 | 2024-05-17 | 2.0 - 3.6 | 1.6 | In |
Put | 2024-05-17 PUT at $35.0 | -0.737 | 0.0451 | 8 | 2024-05-17 | 6.1 - 8.1 | 4.6 | In |
Put | 2024-05-17 PUT at $40.0 | -0.8948 | 0.0268 | 0 | 2024-05-17 | 10.3 - 12.5 | 0.0 | In |
Put | 2024-05-17 PUT at $45.0 | -0.9638 | 0.0118 | 0 | 2024-05-17 | 15.0 - 17.4 | 0.0 | In |
Put | 2024-05-17 PUT at $50.0 | -0.7863 | 0.0195 | 0 | 2024-05-17 | 19.4 - 22.5 | 0.0 | In |
Harmony Biosciences Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Harmony Biosciences Common Stock Shares Outstanding Over Time
The total number of shares of a company's common stock that are currently owned by all its shareholders. Common Stock Shares Outstanding |
| Timeline |
Harmony Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Harmony Biosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run AI Investment Finder Now
AI Investment FinderUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Harmony Biosciences Corporate Management
Elected by the shareholders, the Harmony Biosciences' board of directors comprises two types of representatives: Harmony Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Harmony. The board's role is to monitor Harmony Biosciences' management team and ensure that shareholders' interests are well served. Harmony Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Harmony Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Audrey Murphy | Head Resources | Profile | |
| David Bradshaw | Head Operations | Profile | |
| Cate McCanless | Head Policy | Profile | |
| MBA JD | Executive Officer | Profile | |
| Audrey SPHR | Head Resources | Profile | |
| Jeffrey Aronin | Founder Chairman | Profile | |
| Tricia Glover | Chief Officer | Profile |
Already Invested in Harmony Biosciences Holdings?
The danger of trading Harmony Biosciences Holdings is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Harmony Biosciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Harmony Biosciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Harmony Biosciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Harmony Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Harmony Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Harmony Biosciences Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Harmony Biosciences Holdings Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harmony Biosciences Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Harmony Stock analysis
When running Harmony Biosciences' price analysis, check to measure Harmony Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harmony Biosciences is operating at the current time. Most of Harmony Biosciences' value examination focuses on studying past and present price action to predict the probability of Harmony Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harmony Biosciences' price. Additionally, you may evaluate how the addition of Harmony Biosciences to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |
Is Harmony Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harmony Biosciences. If investors know Harmony will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harmony Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Earnings Share 2.13 | Revenue Per Share 9.787 | Quarterly Revenue Growth 0.313 | Return On Assets 0.1616 |
The market value of Harmony Biosciences is measured differently than its book value, which is the value of Harmony that is recorded on the company's balance sheet. Investors also form their own opinion of Harmony Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Harmony Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harmony Biosciences' market value can be influenced by many factors that don't directly affect Harmony Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harmony Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Harmony Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harmony Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.